Imunon (IMNN) Earnings Date & Reports

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

IMNN is expected to report earnings to rise 13.70% to -61 cents per share on November 16

Q3'26

Est.

$-0.61

Q2'26

Beat

by $0.39

Q1'26

Missed

by $0.69

Q4'25

Missed

by $1.22

Q3'25

Missed

by $0.95

The last earnings report on August 11 showed earnings per share of -54 cents, beating the estimate of -93 cents. With 32.28K shares outstanding, the current market capitalization sits at 9.20M.

View a ticker or compare two or three

IMNN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days